FINWIRES · TerminalLIVE
FINWIRES

Asia Biofuels Update: Malaysian Palm Oil, Crude Oil Price Movements Diverge

-- Malaysian palm oil price movements diverged from crude oil, as a slowdown in exports weighed on futures, despite a rally in the energy market.

The Bursa Malaysia Derivatives' May and June crude palm oil contracts slipped around 0.2% to two-week lows of 4,489 Malaysian ringgit ($1,129.45) per metric ton and 4,532 ringgit/mt, respectively.

Crude oil prices rallied as the US military prepared to begin a blockade of all Iranian ports in the Strait of Hormuz, after the US and Iran failed to reach an agreement during weekend peace talks.

Escalating geopolitical conflict has lifted palm oil prices since late February.

However, industry profits may not totally reflect surging prices as shipping disruptions cut export margins, Malaysian Palm Oil Board director-general Ahmad Parveez told The Star.

Malaysia's key markets in the Middle East may also turn to nearby suppliers as shipping detours around Africa prolong transit times by almost two weeks, Parveez reportedly said.

In the first 10 days of April, Malaysian shipments reportedly dropped between 30.7% and 38.9% versus month-ago levels, according to cargo surveyors. If lower exports are sustained for the whole of April, the trend could reverse a 40.7% month-over-month jump in March shipments.

Anilkumar Bagani of Sunvin Group, as cited by Reuters, said further robust export performance is necessary to facilitate a drop in domestic inventories this month.

CIMB Securities, as cited by New Straits Times, said Malaysian stocks could further fall to 2.2 mmt in April from 2.3 mmt in March, if higher demand is sustained and production declines.

The country's export demand could get a boost from Indonesia's move to raise biodiesel blending to 50% from 40% beginning July 1.

Production, on the other hand, could ease due to fertilizer supply disruptions and El Nino-related risks.

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB